GSK has received an offer from South African pharma company, Aspen, and it's wholly owned subsidiary, Aspen Global Incorporated, for its thrombosis brands and Notre-Dame de Bondeville (NDB ...

Just a day after dropping a $625m cancer asset, GSK has inked a deal worth a potential $2bn to acquire Boston Pharmaceuticals ...

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...

Chloe Thornton, GlobalData's company analyst, also recently observed that GSK has major problems with a lack ... The biggest vaccine brand it has acquired in the deal is Bexsero, a new vaccine ...

In another note of news, a key aide to HHS Secretary Robert F. Kennedy Jr. said that popular GLP-1 weight loss drugs -- Novo Nordisk's ( NVO) Wegovy (semaglutide) and Eli Lilly's ( LLY) Zepbound ...

(Reuters) - GSK on Wednesday said it was "well positioned ... including an unspecified "major" levy on pharmaceuticals, prompting concern given the industry's global supply chain.

GSK has drawn on a vast bank of images and conversations from ... In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with ...